Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1968 1
1969 1
1971 1
1981 1
2002 5
2003 6
2004 8
2005 3
2006 4
2008 6
2009 12
2010 6
2011 11
2012 10
2013 4
2014 7
2015 4
2016 9
2017 1
2018 4
2019 7
2020 5
2021 6
2022 3
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Anandamide receptors.
Di Marzo V, De Petrocellis L, Fezza F, Ligresti A, Bisogno T. Di Marzo V, et al. Among authors: ligresti a. Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):377-91. doi: 10.1054/plef.2001.0349. Prostaglandins Leukot Essent Fatty Acids. 2002. PMID: 12052051 Review.
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer.
Mahmoud AM, Kostrzewa M, Marolda V, Cerasuolo M, Maccarinelli F, Coltrini D, Rezzola S, Giacomini A, Mollica MP, Motta A, Paris D, Zorzano A, Di Marzo V, Ronca R, Ligresti A. Mahmoud AM, et al. Among authors: ligresti a. Pharmacol Res. 2023 Mar;189:106683. doi: 10.1016/j.phrs.2023.106683. Epub 2023 Feb 1. Pharmacol Res. 2023. PMID: 36736415 Free article.
Actions and Regulation of Ionotropic Cannabinoid Receptors.
De Petrocellis L, Nabissi M, Santoni G, Ligresti A. De Petrocellis L, et al. Among authors: ligresti a. Adv Pharmacol. 2017;80:249-289. doi: 10.1016/bs.apha.2017.04.001. Epub 2017 Jun 12. Adv Pharmacol. 2017. PMID: 28826537 Review.
Endocannabinoid metabolic pathways and enzymes.
Ligresti A, Cascio MG, Di Marzo V. Ligresti A, et al. Curr Drug Targets CNS Neurol Disord. 2005 Dec;4(6):615-23. doi: 10.2174/156800705774933104. Curr Drug Targets CNS Neurol Disord. 2005. PMID: 16375679 Review.
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer.
Maccarinelli F, Coltrini D, Mussi S, Bugatti M, Turati M, Chiodelli P, Giacomini A, De Cillis F, Cattane N, Cattaneo A, Ligresti A, Asperti M, Poli M, Vermi W, Presta M, Ronca R. Maccarinelli F, et al. Among authors: ligresti a. Cell Death Discov. 2023 Mar 6;9(1):81. doi: 10.1038/s41420-023-01383-4. Cell Death Discov. 2023. PMID: 36872341 Free PMC article.
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer.
Chiodelli P, Coltrini D, Turati M, Cerasuolo M, Maccarinelli F, Rezzola S, Grillo E, Giacomini A, Taranto S, Mussi S, Ligresti A, Presta M, Ronca R. Chiodelli P, et al. Among authors: ligresti a. Cancer Lett. 2022 Feb 1;526:217-224. doi: 10.1016/j.canlet.2021.11.030. Epub 2021 Dec 1. Cancer Lett. 2022. PMID: 34861311
The endocannabinoid signalling system: biochemical aspects.
Bisogno T, Ligresti A, Di Marzo V. Bisogno T, et al. Among authors: ligresti a. Pharmacol Biochem Behav. 2005 Jun;81(2):224-38. doi: 10.1016/j.pbb.2005.01.027. Pharmacol Biochem Behav. 2005. PMID: 15935454 Review.
128 results